Diagnos Laboratorium Utama Tbk. vs Pratama Widya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.5K 24h volume), while Pratama Widya Tbk. trades at Rp1,145 (market cap 1.01T, 65.5K 24h volume). The key difference: Pratama Widya Tbk. is far larger — about 3.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (129.5K versus 65.5K). Which is the better fit depends on your goals.
| DGNS | PTPW | |
|---|---|---|
Market Cap | 308B | 1.01T |
Volume | 129.5K | 65.5K |
Lot | 1.3K | 655 |
Turnover | 28.69M | 75.51M |
Average Price | 221.54 | 1,152.84 |
Value | 28.69M | 75.51M |
Indicative Equilibrium Price | 230 | 1,150 |
Indicative Equilibrium Volume | 110 | 11.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Pratama Widya Tbk (the Company) was established in the Republic of Indonesia, by deed of notary public Samsul Hadi, S.H., dated 3 June 1981 No. 11, a notary in Jakarta.
Read more on PTPW →